Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

260.47 

-2.30 -0.9%

as of Jul 19 '19

52 Week Range:

228.00 459.75


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides continuum of care to heart failure patients. The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; and Impella CP, a device used by interventional cardiologists to support patients in the cath lab and cardiac surgeons in the heart surgery suite. It also provides Impella 5.0 and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; and Impella RP, a percutaneous catheter-based axial flow pump. In addition, the company is involved in the development of Impella 5.5 and Impella BTR that are percutaneous micro heart pumps with integrated motors and sensors; and Impella ECP pump, a device for blood flow of greater than three liters per minute. It sells its products through direct sales and clinical support personnel in the United States, Canada, Europe, and Japan. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Mar '09 Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19
Equity (BVPS) 3.16
2.88
2.78
3.00
3.52
4.02
4.73
8.11
9.56
14.25
18.87
growth rate -8.9% -3.5% 7.9% 17.3% 14.2% 17.7% 71.5% 17.9% 49.1% 32.4%
Earnings BIT -30.85
-18.35
-10.86
2.54
16.86
8.53
29.18
66.16
91.73
158.47
growth rate 0.0% 0.0% 100.0% 563.8% -49.4% 242.0% 126.8% 38.7% 72.8%
Avg.PE -16.00
-16.10
-33.70
588.24
51.02
147.06
22.54
32.13
118.45
197.83
56.52
growth rate 0.0% 0.0% 100.0% -91.3% 188.2% -84.7% 42.6% 268.7% 67.0% -71.4%
ROA -24.88
-14.33
-9.00
1.05
9.27
3.92
41.81
10.01
10.70
16.78
28.14
growth rate 0.0% 0.0% 100.0% 782.9% -57.7% 966.6% -76.1% 6.9% 56.8% 67.7%
ROE -30.15
-16.99
-11.05
1.29
11.40
4.81
49.44
11.55
12.70
19.65
31.85
growth rate 0.0% 0.0% 100.0% 783.7% -57.8% 927.9% -76.6% 10.0% 54.7% 62.1%
ROIC -30.15
-16.99
-11.05
1.29
11.40
4.81
49.44
11.55
12.21
19.39
31.85
growth rate 0.0% 0.0% 100.0% 783.7% -57.8% 927.9% -76.6% 5.7% 58.8% 64.3%
Cur. Ratio 5.03
4.58
3.79
4.93
4.31
3.88
5.60
6.20
4.70
5.84
6.39
growth rate -9.0% -17.3% 30.1% -12.6% -10.0% 44.3% 10.7% -24.2% 24.3% 9.4%
Quick Ratio 4.15
3.97
3.39
4.36
3.68
3.32
4.17
5.48
4.08
5.10
5.50
growth rate -4.3% -14.6% 28.6% -15.6% -9.8% 25.6% 31.4% -25.6% 25.0% 7.8%
Leverage 1.17
1.20
1.26
1.22
1.24
1.22
1.16
1.15
1.22
1.14
1.13
growth rate 2.6% 5.0% -3.2% 1.6% -1.6% -4.9% -0.9% 6.1% -6.6% -0.9%
Balance Sheet Mar '09 Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19
Acct.Receivable 15.70
13.50
15.40
20.46
22.95
24.36
31.83
42.82
54.06
70.01
growth rate -14.0% 14.1% 32.8% 12.2% 6.2% 30.7% 34.5% 26.2% 29.5%
Acct.Payable 19.39
22.86
25.65
10.39
9.38
20.62
23.57
growth rate 17.9% 12.2% -59.5% -9.7% 119.8% 14.3%
Cur.Assets 88.50
82.70
84.70
110.54
116.61
117.97
185.04
288.39
326.96
494.27
growth rate -6.6% 2.4% 30.5% 5.5% 1.2% 56.9% 55.9% 13.4% 51.2%
Total Assets 136.00
129.60
131.60
153.91
170.00
205.41
338.37
423.93
550.41
786.38
growth rate -4.7% 1.5% 17.0% 10.5% 20.8% 64.7% 25.3% 29.8% 42.9%
Cash 1.80
4.80
5.80
5.99
9.45
20.92
22.40
48.23
39.04
42.98
growth rate 166.7% 20.8% 3.3% 57.8% 121.3% 7.1% 115.3% -19.1% 10.1%
Inventory 14.80
9.20
7.50
11.14
14.93
13.95
16.77
26.74
34.93
50.20
growth rate -37.8% -18.5% 48.6% 34.0% -6.6% 20.3% 59.4% 30.6% 43.7%
Cur.Liabilities 17.60
18.10
22.30
22.42
27.06
30.41
39.32
46.54
69.62
84.68
growth rate 2.8% 23.2% 0.5% 20.7% 12.4% 29.3% 18.4% 49.6% 21.6%
Liabilities 20.00
21.60
26.80
27.61
32.92
37.05
46.81
55.16
98.34
96.85
growth rate 8.0% 24.1% 3.0% 19.2% 12.6% 26.3% 17.8% 78.3% -1.5%
LT Debt 0.00
0.00
0.00
0.00
0.00
15.54
15.54
15.54
growth rate 0.0% 0.0%
Equity 116.00
108.00
104.70
126.30
137.08
168.35
291.56
368.78
452.07
689.52
growth rate -6.9% -3.1% 20.6% 8.5% 22.8% 73.2% 26.5% 22.6% 52.5%
Common Shares 35.00
37.00
37.00
40.00
41.00
42.00
43.00
45.00
45.00
46.00
46.00
growth rate 5.7% 0.0% 8.1% 2.5% 2.4% 2.4% 4.7% 0.0% 2.2% 0.0%
Cash Flow Statement Mar '09 Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19
Capital Expenditures 3.80
1.80
1.80
1.75
2.84
2.76
5.19
15.62
50.42
55.86
growth rate -52.6% 0.0% -3.1% 62.5% -2.6% 87.9% 201.2% 222.7% 10.8%
Cash Dividends 0.00 0.00 0.00 0.00 0.00
growth rate
Cash From OA -18.31
-7.36
1.60
3.63
26.40
23.47
43.29
76.80
115.12
192.55
growth rate 0.0% 100.0% 127.1% 626.4% -11.1% 84.5% 77.4% 49.9% 67.3%
FCF per Share -0.63
-0.25
-0.01
-0.10
0.52
0.44
0.76
1.38
1.54
2.26
4.14
growth rate 0.0% 0.0% 0.0% 100.0% -15.4% 72.7% 81.6% 11.6% 46.8% 83.2%
Sale Purchase of Stock 14.68
-11.55
10.06
11.72
10.91
12.38
11.70
growth rate -100.0% 100.0% 16.6% -7.0% 13.5% -5.5%
FCF -22.00
-9.00
-0.20
2.00
24.00
21.00
38.00
61.00
65.00
137.00
208.00
growth rate 0.0% 0.0% 100.0% 1,100.0% -12.5% 81.0% 60.5% 6.6% 110.8% 51.8%
Income Statement Mar '09 Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19
Sales 73.20
85.70
101.20
126.38
158.12
183.64
230.31
329.54
445.30
593.75
growth rate 17.1% 18.1% 24.9% 25.1% 16.1% 25.4% 43.1% 35.1% 33.3%
Op.Income -29.50
-25.10
-11.20
1.50
15.01
8.36
29.18
66.16
91.73
158.47
growth rate 0.0% 0.0% 100.0% 904.3% -44.3% 248.9% 126.8% 38.7% 72.8%
IBT -30.80
-18.40
-10.90
2.54
16.86
8.53
28.77
65.84
91.34
160.44
growth rate 0.0% 0.0% 100.0% 563.1% -49.4% 237.2% 128.9% 38.7% 75.6%
Net Income -31.60
-19.00
-11.80
1.50
15.01
7.35
113.69
38.15
52.12
112.17
growth rate 0.0% 0.0% 100.0% 904.3% -51.0% 1,446.6% -66.5% 36.6% 115.2%
EPS -0.91
-0.52
-0.32
0.04
0.37
0.18
2.65
0.85
1.17
2.45
5.61
growth rate 0.0% 0.0% 100.0% 825.0% -51.4% 1,372.2% -67.9% 37.7% 109.4% 129.0%
Gross Profit 52.80
63.20
79.20
101.87
126.53
146.32
190.37
279.12
374.68
495.17
growth rate 19.7% 25.3% 28.6% 24.2% 15.6% 30.1% 46.6% 34.2% 32.2%
R&D 25.30
26.00
26.70
27.16
25.65
30.71
35.46
48.71
64.80
73.96
growth rate 2.8% 2.7% 1.7% -5.6% 19.7% 15.5% 37.3% 33.0% 14.1%

Quarterly Statements

Item Name Jun '17 Sep '17 Dec '17 Mar '18 Jun '18
Earnings BIT 33.34
32.14
45.35
47.63
46.59
growth rate -3.6% 41.1% 5.0% -2.2%
Balance Sheet Jun '17 Sep '17 Dec '17 Mar '18 Jun '18
Acct.Receivable 53.56
57.33
64.86
70.01
67.51
growth rate 7.0% 13.1% 7.9% -3.6%
Acct.Payable 12.78
16.67
21.99
23.57
25.67
growth rate 30.4% 31.9% 7.2% 9.0%
Cur.Assets 350.92
370.17
422.20
494.27
497.30
growth rate 5.5% 14.1% 17.1% 0.6%
Total Assets 652.22
694.65
719.60
786.38
812.04
growth rate 6.5% 3.6% 9.3% 3.3%
Cash 43.97
44.54
50.50
42.98
61.29
growth rate 1.3% 13.4% -14.9% 42.6%
Inventory 36.93
40.63
46.89
50.20
55.78
growth rate 10.0% 15.4% 7.1% 11.1%
Cur.Liabilities 59.01
63.36
75.35
84.68
76.68
growth rate 7.4% 18.9% 12.4% -9.5%
Liabilities 85.17
89.77
87.12
96.85
88.68
growth rate 5.4% -3.0% 11.2% -8.4%
LT Debt 15.33
15.11
growth rate -1.4%
Equity 567.04
604.89
632.48
689.52
723.36
growth rate 6.7% 4.6% 9.0% 4.9%
Common Shares 0.44
0.44
0.44
0.44
0.45
growth rate 0.2% 0.2% 0.2% 1.1%
Cash Flow Statement Jun '17 Sep '17 Dec '17 Mar '18 Jun '18
Capital Expenditures 9.80
7.87
26.49
11.70
15.15
growth rate -19.7% 236.6% -55.9% 29.5%
Cash Dividends
growth rate
Cash From OA 36.29
43.16
56.70
56.40
46.63
growth rate 18.9% 31.4% -0.5% -17.3%
Sale Purchase of Stock 3.56
20.57
2.37
22.87
5.80
growth rate 478.6% -88.5% 865.3% -74.7%
FCF 26.49
35.29
30.20
44.70
31.48
growth rate 33.2% -14.4% 48.0% -29.6%
Income Statement Jun '17 Sep '17 Dec '17 Mar '18 Jun '18
Sales 132.47
132.82
154.02
174.44
180.01
growth rate 0.3% 16.0% 13.3% 3.2%
Op.Income 33.34
32.14
45.35
47.63
46.59
growth rate -3.6% 41.1% 5.0% -2.2%
IBT 33.79
32.48
45.65
48.51
48.49
growth rate -3.9% 40.5% 6.3% 0.0%
Net Income 37.37
24.50
13.45
36.85
90.07
growth rate -34.4% -45.1% 174.0% 144.4%
EPS
growth rate
Gross Profit 110.61
111.20
129.03
144.34
149.16
growth rate 0.5% 16.0% 11.9% 3.3%
R&D 16.67
18.97
17.12
21.20
21.43
growth rate 13.8% -9.8% 23.9% 1.1%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

A+ (92.01)

YOY Growth Grade:

B (67.37)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 56.52 54.17 42.93
EPS / Growth 52.3% 4.81 38.0%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 33.7%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 33.7% 41.3% 41.3%
Future PE 42.93 60.68 60.68
Future EPS 87.49 152.54 152.54
Value Price
MOS %
928.47
256.5%
2,288.12
778.5%
2,288.12
778.5%
MOS Price 464.23 1,144.06 1,144.06
IRT 9.22 8.14 8.14

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.